What the market knows is* We are a long way from FDA approval...

What the market knows is
* We are a long way from FDA approval for iPPS
* The MPS market is tinier than tiny
* PRs prognostications on deals have borne no fruit
* The overall ASX is glum
* Any suggestion of moving to ADRs has been steadfastly ignored or treated as too expensive.
* there has always been another CR coming
* the board is dysfunctional
* we have a game-changer product that is a couple of years from FDA approval with the usual caveats

PR is not about to change his nature. We need new Board members who tell him where he fits in. That requires the other large stakeholders to form a coalition that makes that happen.
Instead of engaging with PR, retail investors should be talking to any other large stakeholder about it is time to take control.
Better to do that than lament here.

I can't afford to buy any more PAR, it is too big a hole in my retirement savings.
GLTAH.